The stock of CARGO Therapeutics Inc (CRGX) has seen a 11.29% increase in the past week, with a 0.55% gain in the past month, and a 14.05% flourish in the past quarter. The volatility ratio for the week is 4.43%, and the volatility levels for the past 30 days are at 4.34% for CRGX. The simple moving average for the last 20 days is 5.40% for CRGX stock, with a simple moving average of -54.97% for the last 200 days.
Is It Worth Investing in CARGO Therapeutics Inc (NASDAQ: CRGX) Right Now?
The 36-month beta value for CRGX is also noteworthy at 0.22. There are mixed opinions on the stock, with 0 analysts rating it as a “buy”, 0 rating it as “overweight”, 5 rating it as “hold”, and 0 rating it as “sell”.
The public float for CRGX is 32.85M, and at present, short sellers hold a 9.99% of that float. The average trading volume of CRGX on July 08, 2025 was 648.97K shares.
CRGX stock’s latest price update
The stock price of CARGO Therapeutics Inc (NASDAQ: CRGX) has surged by 4.44% when compared to previous closing price of $4.39, but the company has seen a 11.29% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-07-08 that NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CARGO Therapeutics, Inc. (NASDAQ: CRGX) to Concentra Biosciences, LLC is fair to CARGO shareholders. Under the terms of the proposed transaction, Concentra will acquire CARGO for $4.379 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and (ii) 80% of any net pro.
Analysts’ Opinion of CRGX
Truist, on the other hand, stated in their research note that they expect to see CRGX reach a price target of $7, previously predicting the price at $32. The rating they have provided for CRGX stocks is “Hold” according to the report published on January 30th, 2025.
CRGX Trading at 6.99% from the 50-Day Moving Average
After a stumble in the market that brought CRGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.98% of loss for the given period.
Volatility was left at 4.34%, however, over the last 30 days, the volatility rate increased by 4.43%, as shares sank -3.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.33% upper at present.
During the last 5 trading sessions, CRGX rose by +11.29%, which changed the moving average for the period of 200-days by -80.35% in comparison to the 20-day moving average, which settled at $4.35. In addition, CARGO Therapeutics Inc saw -70.15% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRGX starting from Radhakrishnan Anup, who sold 1,632 shares at the price of $4.18 back on Jul 02 ’25. After this action, Radhakrishnan Anup now owns 120,781 shares of CARGO Therapeutics Inc, valued at $6,822 using the latest closing price.
Radhakrishnan Anup, the See Remarks of CARGO Therapeutics Inc, sale 27,404 shares at $3.84 during a trade that took place back on May 14 ’25, which means that Radhakrishnan Anup is holding 122,413 shares at $105,272 based on the most recent closing price.
Stock Fundamentals for CRGX
The total capital return value is set at -0.76%. Equity return is now at value -65.94%, with -55.12% for asset returns.
Based on CARGO Therapeutics Inc (CRGX), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -4.84.
Currently, EBITDA for the company is -160.43 million with net debt to EBITDA at 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.30.
Conclusion
In summary, CARGO Therapeutics Inc (CRGX) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
